Because MPM is more aggressive than pulmonary adenocarcinoma (ADC), Attanoos and coworkers [80] tested the diagnostic potential of CD44 to discriminate the two neoplasms by immunohistochemistry (IHC) in reactive mesothelium, pleural mesothelioma and pulmonary ADC. This evidence concerns the gene CD44 and AIDS dementia complex.